Diabetes Mellitus, Type 2 Clinical Trial
Official title:
GLUCOME USABILITY STUDY
The GlucoMe device, in its original packaging, along with the user manual and QuickStart
guide will be provided to the patient in a simulated home use environment. The patient
labeling will be in the format intended for distribution.
Ten (10) subjects identified as potential end users of the GlucoMe device will receive the
user manual. An additional ten (10) subjects also identified as potential end users of the
GlucoMe device will NOT receive the user manual. All subjects will be provided with a
pre-test and post-test questionnaire and a list of tasks to complete, including applying and
operating the device.
The observer and user post-test questionnaire will collect information regarding device use.
The device's use will be compared with identified risks to determine if the percentage of
failures is within the study protocol success criteria. Additionally, measurable usability
criteria for specific, critical steps will be evaluated.
Twenty (20) subjects identified as potential end users of the device will be recruited to the
study and screened according to the study inclusion and exclusion criteria. Subjects will be
asked to sign informed consent. The GlucoMe device, in its original packaging, along with the
user manual and QuickStart guide will be provided to the patient in a simulated home-use
environment. The patient labeling will be in the format intended for distribution.
Ten (10) subjects identified as potential end users of the GlucoMe device will receive the
user manual and QuickStart guide. An additional ten (10) subjects also identified as
potential end users of the GlucoMe device will not receive the user manual, but will receive
the QuickStart guide. All subjects will be provided with a pre-test and post-test
questionnaire and a list of tasks to complete, including applying and operating the device.
The observer examination and user post-test questionnaire will collect information regarding
device use. The device's use will be compared with identified risks to determine if the
percentage of failures is within the study protocol success criteria. Additionally,
measurable usability criteria for specific, critical steps will be evaluated.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |